Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Cantor Fitzgerald Reiterates Overweight Rating on Trevi Therapeutics (TRVI)
-
Trevi (TRVI) First to Show Positive IPF Chronic Cough, RCC Data - Cantor Fitzgerald
-
Cantor Fitzgerald Starts Trevi Therapeutics (TRVI) at Overweight
-
Trevi Therapeutics Announces Closing of $115 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Trevi Therapeutics (TRVI) Offering 17.4M Shares at $5.75
-
Trevi Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock
-
Trevi Therapeutics (TRVI) Announces Proposed $100M Share Offering
-
Trevi Therapeutics Announces Proposed Public Offering of Common Stock
-
Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update
